Catalog number: 1311NAP
Publication date: December 2013
Company-wide electronic copy: $3,975
Please inquire about single-user* electronic copy pricing
*single-user pricing is intended for small companies, of 40 or less employees. Please order these copies directly with Percepta Associates.
Introduction
Nucleic acid purification is one of the few basic methods ubiquitous among scientists using molecular biology techniques to investigate processes such as gene expression, genetic diversity, protein function and molecular interactions. As life science suppliers continue improving products and services in the nucleic acid purification market, nucleic acid purification experiment kits and reagents represent a significant market within the life sciences industry.
Percepta’s 2013 Nucleic Acid Purification Dashboard™ is the fourth in a series that characterizes the dynamic market for products for nucleic acid purification experiments. This 2013 Dashboard provides a snapshot of the current market landscape that is compared with data from the 2011 and 2009 Nucleic Acid Purification Dashboards where relevant, providing an ongoing story of how the market is adapting to new products, new competitors and new sales and marketing strategies.
The 2013 Nucleic Acid Purification Dashboard™ was developed from responses to a 24-question survey completed by 560 scientists located in North America and Europe. This Dashboard reveals key market indicators for the nucleic acid purification market as a whole as well as for the following techniques representing market sub-segments:
- Gel extraction
- Post-reaction cleanup (i.e. PCR, enzyme digestion)
- Plasmid DNA minipreps (1-2 ml culture)
- Plasmid DNA midipreps (5-50 ml culture)
- Plasmid DNA maxipreps (100 ml culture or more)
- Genomic DNA from cells or tissue
- Genomic DNA from whole blood
- Genomic DNA from FFPE tissue
- NGS library prep (DNA)*
- NGS library prep (RNA)*
- Total RNA from cells or tissue
- Total RNA from whole blood
- Total RNA from FFPE tissue
- mRNA
- microRNA
*New product segments as of this report.
Survey Methodology
In September/October of 2013, Percepta fielded the Nucleic Acid Purification Survey to a subset of the company’s panel of life scientists. Individuals were invited by e-mail blast to click through to a webpage at perceptabioanalytix.com where the survey was hosted. Invitations were delivered on September 25, 2013 and results collected through October 1, 2013. A total of 560 scientists completed the survey. Results are based on the aggregate of collected responses.
List of Companies Surveyed
Please note that respondents were provided with an option to list other suppliers.
- Affymetrix/USB
- Agilent/Stratagene
- Beckman Coulter/Agencourt
- Bio Basic
- Bio-Rad
- Cambio
- Exiqon
- GE healthcare
- Geneaid
- Illumina/Epicentre
- IntegenX
- Life Technologies/Invitrogen/Ambion
- Macherey Nagel
- Mo Bio
- MP Biomedicals/Qbiogene
- New England Biolabs
- Omega Bio-Tek
- Promega
- Qiagen/SABiosciences
- Roche Applied Science
- Sigma Aldrich
- TaKaRa/Clontech
- Thermo Fisher Scientific
- Zymo Research
- 5 Prime
Table of Contents
5 Executive Summary
8 Dashboard “At A Glance”
14 Market Opportunity Matrix
16 Respondents Qualification
18 Demographics
21 Frequency of Performance: Life Science Techniques
25 Frequency of Performance: Nucleic Acid Purification
60 Co-Performance: Nucleic Acid Purification Experiments & Life Science Techniques
63 Reagent Format Preference
68 Throughput, Growth Rates, Price & Monthly Spend
80 Market Size
82 Market Shares by Segment (Share of Mentions)
128 Customer Satisfaction & Interest in Switching
133 Purchase Decision Factors: Product Features
137 Primary Downstream Application
152 Desired Product Changes
169 Appendix I: Supporting Data
184 Appendix II: Percepta Capabilities and Life Science Dashboards™ Available
Available upon request